GlassScriptPhysician profile
David Michael Privitera
NPI 1487809919
$6,852.27
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,341 · 2020: $49.21 · 2021: $198 · 2022: $36.20 · 2023: $384 · 2024: $1,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,512 · Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,512.33 |
| Food and Beverage | $716.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,155.55 | 2019-2023 | Na, Lens 4k |
| Arthrex, INC. | $1,934.51 | 2023-2024 | |
| Stryker Corporation | $1,529.56 | 2019-2023 | Variax, Insignia |
| Zimmer Biomet Holdings, INC. | $843.98 | 2019 | |
| Prodigy Surgical Distribution, INC. | $194.87 | 2024 | |
| Ermi LLC | $40.51 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $33.28 | 2021-2022 | |
| Pacira Therapeutics, INC. | $26.23 | 2020 | |
| Anika Therapeutics, INC. | $22.19 | 2021 | |
| Bioventus LLC | $18.62 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.64 | 2020 | |
| Horizon Therapeutics Plc | $15.62 | 2021 | |
| Avanos Medical | $14.37 | 2021 | |
| Heraeus Medical, LLC. | $7.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Privitera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.